• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

453 例多汗症患者行胸腔镜交感神经切断术后生活质量随时间的评估。

Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy.

机构信息

Discipline of Vascular Surgery, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil.

出版信息

J Vasc Surg. 2012 Jan;55(1):154-6. doi: 10.1016/j.jvs.2011.07.097. Epub 2011 Nov 1.

DOI:10.1016/j.jvs.2011.07.097
PMID:22047833
Abstract

OBJECTIVES

Current data do not provide enough information on how quality of life (QoL) evolves over time in cases of endoscopic thoracic sympathectomy (ETS). The purpose of this study was to ascertain whether the immediate improvement in QoL after the surgery was sustained until the fifth postoperative year.

METHODS

This was a prospective, nonrandomized and uncontrolled study. From March 2001 to December 2003, 475 consecutive patients with hyperhidrosis submitted to ETS were included. A QoL questionnaire was applied at the preoperative day, around the 30th postoperative day, and after the fifth year.

RESULTS

After excluding 22 patients who did not answer all the questions, we analyzed 453 patients. Their ages ranged from 11 to 57 years old, with a mean of 25.3 + 7.9 years, including 297 female patients (65.6%). All patients were assessed on three occasions: before surgery, around the 30th postoperative day, and after the fifth postoperative year. The QoL before surgery was considered to be poor or very poor for all patients. The QoL around 30 days after surgery was better in 412 patients (90.9%), the same in 27 patients (6.0%), and worse in 14 patients (3.1%). After 5 years, 409 patients (90.3%) were better, 27 (6.0%) were the same, and 14 (3.1%) were worse. There were no differences between these postoperative times according to the McNemar statistical test.

CONCLUSION

The patients had an immediate improvement in QoL after ETS, and this improvement was sustained until the fifth postoperative year.

摘要

目的

目前的资料尚不能充分说明胸腔镜胸交感神经切断术(ETS)后患者的生活质量(QoL)随时间的变化情况。本研究旨在确定手术后 QoL 的即刻改善是否能持续到术后第 5 年。

方法

这是一项前瞻性、非随机和非对照研究。2001 年 3 月至 2003 年 12 月,我们共纳入 475 例多汗症患者,均接受 ETS 治疗。在术前、术后 30 天左右以及术后第 5 年,我们应用 QoL 问卷进行调查。

结果

排除未回答所有问题的 22 例患者后,我们共分析了 453 例患者。他们的年龄为 11-57 岁,平均 25.3 ± 7.9 岁,包括 297 例女性(65.6%)。所有患者均在 3 个时间点进行评估:术前、术后 30 天左右以及术后第 5 年。所有患者术前 QoL 被认为较差或极差。412 例(90.9%)患者术后 30 天 QoL 改善,27 例(6.0%)相同,14 例(3.1%)变差。术后 5 年,409 例(90.3%)患者 QoL 改善,27 例(6.0%)相同,14 例(3.1%)变差。McNemar 统计检验显示这些术后时间点之间 QoL 无差异。

结论

ETS 后患者的 QoL 即刻改善,这种改善可持续至术后第 5 年。

相似文献

1
Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy.453 例多汗症患者行胸腔镜交感神经切断术后生活质量随时间的评估。
J Vasc Surg. 2012 Jan;55(1):154-6. doi: 10.1016/j.jvs.2011.07.097. Epub 2011 Nov 1.
2
Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy.453例接受内镜下胸交感神经切除术的多汗症患者生活质量随时间的评估。
J Vasc Surg. 2012 Jan;55(1):291. doi: 10.1016/j.jvs.2011.11.046.
3
Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis.手术前的生活质量是接受交感神经切除术治疗多汗症的患者满意度的预测因素。
J Vasc Surg. 2010 May;51(5):1190-4. doi: 10.1016/j.jvs.2009.11.078. Epub 2010 Mar 29.
4
Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases.单孔胸腔镜胸交感神经切除术治疗手掌及腋窝多汗症:2000例分析
Neurosurgery. 2002 Nov;51(5 Suppl):S84-7.
5
Predicting improvement after surgery for palmar hyperhidrosis.预测手掌多汗症手术后的改善情况。
Acta Neurol Scand. 2012 Nov;126(5):324-8. doi: 10.1111/j.1600-0404.2012.01650.x. Epub 2012 Feb 10.
6
Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4.对接受T3和T4两个节段交感神经切除术的手掌多汗症患者进行客观评估。
Interact Cardiovasc Thorac Surg. 2011 Apr;12(4):545-8. doi: 10.1510/icvts.2010.252015. Epub 2011 Jan 13.
7
Awake one stage bilateral thoracoscopic sympathectomy for palmar hyperhidrosis: a safe outpatient procedure.清醒状态下单阶段双侧胸腔镜交感神经切除术治疗手掌多汗症:一种安全的门诊手术。
Eur J Cardiothorac Surg. 2005 Aug;28(2):312-7; discussion 317. doi: 10.1016/j.ejcts.2005.03.046.
8
The effect of thoracoscopic sympathectomy on quality of life and symptom management of hyperhidrosis.胸腔镜交感神经切除术对多汗症患者生活质量及症状管理的影响。
J Am Coll Surg. 2007 Mar;204(3):435-8. doi: 10.1016/j.jamcollsurg.2006.12.007. Epub 2007 Jan 30.
9
Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility.胸腔镜下交感神经夹闭术治疗多汗症:长期疗效及可逆性
J Thorac Cardiovasc Surg. 2009 Jun;137(6):1370-6; discussion 1376-7. doi: 10.1016/j.jtcvs.2009.01.008.
10
Endoscopic transthoracic sympathectomy for upper limb hyperhidrosis: limited sympathectomy does not reduce postoperative compensatory sweating.内镜下经胸交感神经切除术治疗上肢多汗症:局限性交感神经切除术并不能减少术后代偿性出汗。
J Vasc Surg. 2003 Jan;37(1):124-8. doi: 10.1067/mva.2002.23.

引用本文的文献

1
Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.奥昔布宁与六水合氯化铝治疗原发性手掌多汗症的疗效、安全性及生活质量比较
Indian J Dermatol. 2022 May-Jun;67(3):222-227. doi: 10.4103/ijd.IJD_799_20.
2
Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study.基于人群的 11 年间 1216 例多汗症手术矫正流行病学分析:一项横断面研究。
Sao Paulo Med J. 2022 Nov-Dec;140(6):775-780. doi: 10.1590/1516-3180.2021.0773.R2.14022022.
3
Cohort study on 20 years' experience of bilateral video-assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients.
2431 例患者双侧电视辅助胸腔镜交感神经切断术(VATS)治疗多汗症 20 年经验的队列研究。
Sao Paulo Med J. 2022 Mar-Apr;140(2):284-289. doi: 10.1590/1516-3180.2021.0078.R1.23072021.
4
Thoracic sympathectomy for the treatment of primary axillary hyperhidrosis: systematic review and proportional meta-analysis.胸腔镜胸交感神经切断术治疗原发性腋窝多汗症:系统评价和比例荟萃分析。
Ann Med. 2021 Dec;53(1):1216-1226. doi: 10.1080/07853890.2021.1953126.
5
Current treatment options for craniofacial hyperhidrosis.颅面部多汗症的当前治疗选择。
J Vasc Bras. 2020 Nov 16;19:e20190152. doi: 10.1590/1677-5449.200152.
6
Is there any relationship between quality of life and the level of sympathectomy in primary palmar hyperhidrosis? Single-center experience.原发性掌部多汗症患者的生活质量与交感神经切除术水平之间存在关联吗?单中心经验。
Gen Thorac Cardiovasc Surg. 2020 Mar;68(3):273-279. doi: 10.1007/s11748-019-01210-7. Epub 2019 Sep 21.
7
Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art.奥昔布宁治疗原发性多汗症:当前技术水平
Skin Appendage Disord. 2015 Mar;1(1):6-13. doi: 10.1159/000371581. Epub 2015 Jan 30.
8
Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency.原发性腋窝多汗症患者在接受分次微针射频治疗前后的生活质量
J Res Med Sci. 2015 Jul;20(7):631-5. doi: 10.4103/1735-1995.166196.
9
Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.巴西塞尔希培州医学生原发性多汗症的研究。
An Bras Dermatol. 2015 Sep-Oct;90(5):661-5. doi: 10.1590/abd1806-4841.20153859.
10
Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years.40岁以上患者使用奥昔布宁治疗多汗症的分析。
Einstein (Sao Paulo). 2014 Jan-Mar;12(1):42-7. doi: 10.1590/s1679-45082014ao2841.